Here is a question worth taking literally: how does a sum of money reliably arrive, in full, at exactly the moment of your death, when you are by definition not around to authorize the transfer? That is the entire funding problem in one sentence. The preservation fee is large, the timing is unforgiving, and the person who wanted it is no longer available to make it happen. Every funding method below is really just a different answer to that one question.
The good news is that the most common answer is also the cheapest and the most boring, which is exactly what you want from a financial instrument that has to work without you.
Term life insurance: the default for a reason
Term life insurance provides pure death-benefit protection for a fixed period, typically 10, 20, or 30 years, in exchange for level premiums. You choose the term length and the coverage amount; if you die during the term, the insurer pays the full benefit, tax-free, to your named beneficiary. Point that beneficiary at Tomorrow Biostasis GmbH and the money flows straight to your preservation, no family action required.
You can do this two ways. Through our insurance partner, VKB, we handle the whole thing: you fill out the application form we send, we submit it, manage underwriting, and ensure VKB pays us directly to cover your cryopreservation. Or you use any term-life provider in your own country and simply designate Tomorrow Biostasis GmbH as beneficiary. Either way the death benefit lands where it needs to. The mechanics and the age-related pricing are covered in depth in term and whole life insurance.
Whole life insurance: lifelong, with a savings component
Whole-life insurance provides lifelong coverage with fixed premiums, and part of each payment funds a cash-value account that grows tax-deferred. The policy never expires as long as premiums are paid, and the cash value builds guaranteed savings you can borrow against or withdraw.
We will argue against it honestly, because calibration matters more than salesmanship: premiums are far higher than term policies, the cash-value growth is modest and eroded by fees and surrender charges, and accessing that cash may incur interest and reduce the death benefit. Whole life is best understood as a complement to term coverage, not a replacement for it, particularly for funding that needs to outlast a fixed term.
Trusts: for the very long view
A discretionary trust for cryopreservation is a specialized legal structure with two jobs: covering all costs associated with your preservation contract, and providing financial resources for you if revival ever becomes possible. The trust is funded, pays for the preservation services, then invests and grows the remaining capital over the storage period. If revival ever arrives, the accumulated funds give the revived person resources to restart a life in whatever future they wake into.
For UK residents in particular, a discretionary trust is the most flexible and tax-efficient route. Trustees can adapt funding decisions as technologies and requirements evolve over potentially centuries; properly structured trusts offer significant inheritance-tax advantages while ring-fencing funds for preservation; and experienced trustees manage investment and distribution without rigid beneficiary constraints. Most clients fund the trust through a life insurance policy owned by the trust, which keeps funds immediately available at legal death. It does require multiple potential beneficiaries to meet UK legal standards, a professional trust deed, and ongoing compliance with UK trust taxation and reporting. This is wealth-management territory, and it pairs naturally with the strategies in wealth management tips for cryopreservation.
Pre-payment and the case-by-case lane
Pre-payment is the direct route: you pay Tomorrow.bio directly, bypassing insurance or trusts. We accept it when a patient has a confirmed medical prognosis with a life expectancy of less than 12 months, or when a patient is in critical condition or has recently passed and immediate arrangements are required. It exists for the time-sensitive situations where slower funding methods simply cannot be set up in time.
There is also an alternative-funding lane for arrangements that do not fit the standard categories but can provide immediate liquidity before the procedure. These are evaluated case by case and require a consultation call to assess feasibility. One method we explicitly cannot accept is a Last Will arrangement, and the reason is operational rather than philosophical: Tomorrow.bio must advance 120,000 EUR to the Patient Care Trust immediately upon cryopreservation, but Last Will payments cannot be guaranteed or processed quickly enough to cover that upfront cost. The mismatch in timing creates an unacceptable financial risk, which is the same structural failure that makes family-funded preservation at death risky.
Every funding method is one answer to a single question: how does the money arrive, in full, at the moment of death, without you there to send it? Insurance answers it best, which is why most people choose it.
If you are starting from scratch and want the cheapest reliable path, the honest recommendation is term life insurance, set up young. Everything else is refinement on top of that foundation. Choose the term with its expiry in mind: a policy that lapses while you are still alive leaves the preservation unfunded, and replacing that coverage later means requalifying at an older age. The practical steps are in setting up a funding method.